Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study

We studied the clinical and immunological effects of Rituximab (anti-CD20) therapy in patients with lupus nephritis. In an open clinical trial, 22 patients with active systemic lupus erythematosis and renal involvement (mainly class III and IV according to the WHO classification) that was refractory...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vigna-Perez, Mónica, Hernández-Castro, Berenice, Paredes-Saharopulos, Octavio, Portales-Pérez, Diana, Baranda, Lourdes, Abud-Mendoza, Carlos, González-Amaro, Roberto
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2006
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1526618/
https://ncbi.nlm.nih.gov/pubmed/16677395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1954
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados